<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serious <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, and immunologic abnormalities have been found in homosexual men </plain></SENT>
<SENT sid="1" pm="."><plain>We describe the development of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in six such patients, three of whom had persistent, <z:hpo ids='HP_0008940'>generalized lymphadenopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In biopsies done before the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> developed, the <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> was characterized morphologically by a distinctive pattern of B-cell <z:hpo ids='HP_0002729'>follicular hyperplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were of B-lymphocytic origin, including B-cell <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0100242'>sarcoma</z:hpo>; small noncleaved, Burkitt-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; and plasmacytoid lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Extranodal presentation with B symptoms occurred in five patients </plain></SENT>
<SENT sid="5" pm="."><plain>Median age of our patients was 33 years </plain></SENT>
<SENT sid="6" pm="."><plain>Three patients had histories of repeated <z:e sem="disease" ids="C0243026" disease_type="Disease or Syndrome" abbrv="">systemic infections</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The peripheral blood lymphocyte count was depressed in four, with <z:hpo ids='HP_0000716'>depression</z:hpo> of OKT 4+ (helper phenotype) cell levels and reversal of the T-helper: T-suppressor ratio in <z:hpo ids='HP_0000001'>all</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that these patients are at risk for the development of abnormalities of the B-lymphocytic system, manifested by abnormal hyper-B-cell response in enlarged reactive lymph nodes and aggressive, extranodal B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>